Esophageal squamous cell carcinoma (SCC) is a malignant tumor originating from the squamous epithelium of the esophagus and is the most common type of esophageal cancer worldwide (90% in developing countries). Most commonly located in the upper and mid-esophagus. Male-to-female ratio is 3-4:1. Major risk factors are alcohol and tobacco use; additionally, hot beverage consumption, achalasia, caustic stricture, and Plummer-Vinson syndrome increase risk. Over 50% of patients present at advanced stage at diagnosis. Overall 5-year survival is approximately 15-25%; early stage (T1) cases may achieve >90% cure rate with endoscopic mucosal resection.
Age Range
50-80
Peak Age
65
Gender
Male predominant
Prevalence
Common
Esophageal SCC develops through sequential dysplasia stages from normal squamous epithelium (mild → moderate → severe dysplasia → carcinoma in situ → invasive carcinoma). Synergistic effects of alcohol and tobacco cause p53 and p16 tumor suppressor gene mutations and cyclin D1 overexpression. Carcinogens directly induce mucosal DNA damage. The tumor tends to spread along the submucosal lymphatic network — due to the esophagus' rich submucosal lymphatic plexus, longitudinal spread is common, leading to skip lesions. This spread pattern forms the basis of enhancing wall thickening and periesophageal lymphadenopathy on CT. Circumferential tumor growth causes luminal narrowing and proximal dilation — appearing as irregular stricture and 'apple-core' lesion on barium.
Irregular, circumferential luminal narrowing on barium esophagram with shelf-like abrupt margins and mucosal destruction. This appearance is the classic barium finding of circumferentially growing tumors (SCC and adenocarcinoma). Distinguished from benign strictures by irregular borders, asymmetry, and mucosal destruction.
Irregular, circumferential luminal narrowing on barium — 'apple-core' lesion. Lesion margins are irregular with shelf-like overhanging edges. Mucosal destruction and ulceration areas are seen. Lesion is typically 3-8 cm in length. Proximal esophageal dilation may be present.
Report Sentence
Irregular circumferential luminal narrowing (apple-core lesion) measuring approximately ___ cm in length in the mid/distal esophagus is seen, and esophageal squamous cell carcinoma should be the primary consideration.
Asymmetric, circumferential or semi-circumferential wall thickening (>5 mm, usually >15 mm) on contrast-enhanced CT. The thickened segment shows heterogeneous enhancement. Luminal narrowing and proximal dilation are seen. Obliteration of periesophageal fat planes indicates local invasion.
Report Sentence
Asymmetric wall thickening (maximum thickness ___ mm) with heterogeneous enhancement over approximately ___ cm at the ___ level of the esophagus; consistent with esophageal carcinoma.
Periesophageal, subcarinal, paratracheal, and/or celiac lymphadenopathies. Short axis >10 mm is considered pathological. Lymph nodes may enhance or show central necrosis. Distant lymphadenopathy (cervical, retroperitoneal) indicates advanced disease.
Report Sentence
Multiple lymphadenopathies with short axis up to ___ mm in the periesophageal/mediastinal region; consistent with metastatic lymphadenopathy.
Prominent FDG uptake in the primary tumor (SUVmax typically 5-25). Gold standard for staging — demonstrates locoregional and distant metastases with high sensitivity. May be false negative in T1 tumors. High SUVmax is a poor prognostic factor.
Report Sentence
Wall thickening at the ___ level of the esophagus demonstrating prominent FDG uptake with SUVmax ___ is seen, consistent with a malignant process.
Tracheoesophageal fistula may develop in advanced SCC due to tumor invasion of the trachea or main bronchi. CT shows air-containing tract between tumor and airway, and if oral contrast was administered, contrast passage into the airway. Mediastinitis findings may be associated.
Report Sentence
A fistula tract is observed between the esophageal tumor and ___; consistent with tracheoesophageal fistula (T4b stage).
The tumor shows intermediate hyperintense signal on T2-weighted sequences. Necrotic areas are markedly hyperintense. Superior to CT in evaluating tumor margins and deep tissue invasion. Mediastinal and vascular invasion can be better evaluated with MRI.
Report Sentence
Wall thickening with intermediate hyperintense signal on T2-weighted sequences is observed in the esophagus with necrotic components.
Criteria
Polypoid mass protruding into the lumen. Most common type (60%).
Distinct Features
Prominent intraluminal mass component on CT. Filling defect on barium. Later obstruction.
Criteria
Predominantly superficial ulceration and mucosal destruction. Wall thickening may be minimal.
Distinct Features
Mucosal irregularity on barium, 'meniscus' sign. Difficult to detect on CT in early stage. Endoscopy superior.
Criteria
Concentric luminal narrowing with circumferential wall infiltration. Typical apple-core lesion.
Distinct Features
Early obstructive symptoms (dysphagia). Marked circumferential wall thickening on CT. Best prognosis.
Distinguishing Feature
Adenocarcinoma localizes at distal esophagus/GEJ while SCC prefers mid-esophagus; adenocarcinoma arises from Barrett background
Distinguishing Feature
Lymphoma shows more homogeneous enhancement, longer segment involvement, and submucosal spread; SCC has dominant ulceration and mucosal destruction
Distinguishing Feature
Benign stricture has smooth borders, symmetric narrowing, and preserved mucosa; SCC shows irregular borders, shelf-like margins, and mucosal destruction
Distinguishing Feature
Esophagitis shows diffuse mucosal thickening and subepithelial edema (target sign); SCC shows focal asymmetric mass with irregular enhancement
Distinguishing Feature
Metastasis usually appears as eccentric, submucosal mass with preserved mucosa; SCC is mucosal origin with ulceration and mucosal destruction
Urgency
urgentManagement
surgicalBiopsy
NeededFollow-up
specialist-referralHistopathological confirmation with endoscopic biopsy is mandatory. Staging is performed with CT (thorax + abdomen) and PET-CT. EUS (endoscopic ultrasound) is the most accurate method for T and N staging. In early stage (T1a) cases, endoscopic mucosal resection may be curative. In locally advanced (T2-T4a, N+) cases, neoadjuvant chemoradiotherapy (CROSS regimen) + surgery (esophagectomy) is standard treatment. In T4b cases (aortic, tracheal, vertebral invasion), surgery is contraindicated; definitive chemoradiotherapy is applied.
Treatment of esophageal SCC is stage-dependent. Early stage disease is treated with endoscopic resection or surgery. Locally advanced disease requires neoadjuvant chemoradiation + surgery (CROSS regimen). Metastatic disease is treated with palliative chemotherapy and immunotherapy.